Cormedix (CRMD) Stock Price, Quote, News & History | Benzinga

Cormedix Inc (CRMD) Stock Price, Quote, News & History

CRMDNASDAQ

Trade with Public

Trade with Public

$8.36

-0.09-1.07%

Last update: Jun 2, 11:09 AM

OverviewNews Earnings Events Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$8.40

Close

-

Volume / Avg.

239.01K / 1.35M

Day Range

$8.29 - $8.41

52 Wk Range

6.13 - 17.43

Market Cap

$655.86M

P/E Ratio

3.89

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

20.07%

Days to Cover

10.67

Recent CorMedix Inc News

CorMedix Stock Jumps As DefenCath Fuels Q1 Beat, 2026 Outlook Raised

CorMedix raises 2026 guidance after Q1 revenue surges on strong DefenCath demand and higher profitability.

Vandana Singh

CorMedix Eyes $2 Billion Market With Encouraging Data From Fungal Infection Study

CorMedix says Phase 3 ReSPECT data show rezafungin is non-inferior in fungal prevention, supporting FDA filing plans and a $2 billion market outlook.

Vandana Singh

CorMedix Q3 Profit Soars As DefenCath Dialysis Demand Exceeds Expectations

CorMedix posts strong Q3 results with $104 million in revenue, higher DefenCath sales, and raises 2025 guidance following Melinta integration progress.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

197.69M

Investing Cash Flow (TTM)

-305.27M

Financing Cash Flow (TTM)

220.26M

Free Cash Flow (TTM)

194.71M

Capital Expenditure (TTM)

-2.98M

Net Change in Cash (TTM)

112.68M

Analyst Trends and Forecast

1

Dec 25

4

Jan

1

Feb

1

Mar

4

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$629.72M

PE Ratio (TTM)

3.89

PE Ratio (FWD)

16.56

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.82

PB Ratio (TTM)

1.52

Earnings Yield % (TTM)

25.68%

Earnings Yield % (FWD)

6.04%

EV / EBITDA (TTM)

2.85

Price / EBITDA (TTM)

3.30

Price / Free Cash Flow (TTM)

3.75

Book Value / Share

$5.57

Company Debt

Total Debt

$144.89M

LT Debt

$144.89M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$178.09M

Debt to Equity

0.33

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$8.40

Close

-

Volume / Avg.

239.01K / 1.35M

Day Range

$8.29 - $8.41

52 Wk Range

6.13 - 17.43

Market Cap

$655.86M

P/E Ratio

3.89

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

20.07%

Days to Cover

10.67

About

Sector

Health Care

Industry

Pharmaceuticals

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States a...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Cormedix (CRMD) stock?

A

You can purchase shares of Cormedix (NASDAQ:CRMD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cormedix (CRMD) competitors?

A

There are no as such competitors for Cormedix.

Q

What is the forecast, or price target, for Cormedix (CRMD) stock?

A

Cormedix has a consensus price target of $15.64.

Q

What is the current price for Cormedix (CRMD)?

A

The stock price for Cormedix (NASDAQ: CRMD) is $8.36 last updated June 2, 2026 at 11:09 AM EDT.

Q

Does Cormedix (CRMD) pay a dividend?

A

There are no upcoming dividends for Cormedix.

Q

When is Cormedix (NASDAQ:CRMD) reporting earnings?

A

Cormedix does not have any upcoming earnings scheduled.

Q

Is Cormedix (CRMD) going to split?

A

There is no upcoming split for Cormedix.

Q

What sector and industry does Cormedix (CRMD) operate in?

A

Cormedix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.